Tariff Trouble: The Unintended Consequences of Trump's Generic Drug Gambit The latest salvo in President Trump's trade wars is a proposal to impose 100% tariffs on generic drugs imported into the US, starting in 2028.
This move appears to be another instance of the administration's "America First" policy, aimed at reshoring pharmaceutical production and protecting American jobs.
However, experts warn that the consequences of such a drastic measure could be far more complex – and potentially devastating for patients.